Cellular senescence in normal and premature lung aging
1Klinik und Poliklinik für Herz- und Thoraxchirurgie, Universitätsklinikum Halle (Saale) AöR, Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany, babett.bartling@uk-halle.de.
Zeitschrift Fur Gerontologie Und Geriatrie
|August 29, 2013
Summary
Cellular senescence, the aging of lung cells, contributes to age-related respiratory diseases like COPD and lung fibrosis. Targeting these senescent cells may offer new therapeutic strategies for lung aging and disease.
Area of Science:
- Pulmonary Medicine
- Cellular Biology
- Gerontology
Background:
- Chronic respiratory diseases, including COPD and lung fibrosis, show increased incidence with aging.
- Immune senescence and direct accumulation of senescent cells in lung tissue are implicated in pulmonary disease prevalence.
Purpose of the Study:
- To investigate the role of cellular senescence in normal lung aging.
- To explore the contribution of senescent cells to the pathogenesis of COPD and lung fibrosis.
Main Methods:
- Identification and characterization of senescent cells in aging and diseased lung tissues.
- Analysis of risk factors (e.g., smoking, pollution) as mediators of cellular senescence in the lung.
Main Results:
- Senescent cells are present in aging lungs and in lungs of patients with COPD and lung fibrosis.
- Senescence affects various lung cell types, including epithelial, mesenchymal, and vascular cells.
- Environmental risk factors are identified as potential inducers of lung cellular senescence.
Conclusions:
- Cellular senescence plays a significant role in normal lung aging.
- Cellular senescence contributes to premature lung aging and the development of COPD and lung fibrosis.
- Further research into senolytic therapies may benefit patients with respiratory diseases.
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...